Vir Biotechnology (VIR) Stock: $125 Price Target And Buy Rating

By Amit Chowdhry ● May 15, 2022
  • The shares of Vir Biotechnology Inc (NASDAQ: VIR) have received a $125 price target from H.C. Wainwright. These are the details.

The shares of Vir Biotechnology Inc (NASDAQ: VIR) have received a $125 price target from H.C. Wainwright. And H.C. Wainwright analyst Patrick Trucchio is maintaining a “Buy” rating on the shares.

Trucchio had moderated expectations for the COVID-19 franchise. But Trucchio remains positive on Vir shares mainly driven by the strength of the pipeline and $2.5 billion capital positioning.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.